SCHEMBL5227055

SCHEMBL5227055

CC(=O)ON(Cc1cccc(OCCc2nc(-c3ccc(C)cc3)oc2C)c1)S(=O)(=O)N(C)C

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.58
PPARA Q07869 20/20 0.58
CYP2C9 P11712 4/20 0.51
KCNH2 Q12809 4/20 0.51
PPARD Q03181 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5261705 0.90 PPARG (0.55) PPARGPPARAPPARD
SCHEMBL5228134 0.87 PPARG (0.51) PPARGPPARAPPARD
SCHEMBL5227322 0.86 PPARG (0.54) PPARGPPARACYP2C9KCNH2
SCHEMBL5259761 0.86 PPARA (0.53) PPARGPPARACYP2C9KCNH2
SCHEMBL5227014 0.85 PPARG (0.55) PPARGPPARACYP2C9KCNH2
SCHEMBL5226444 0.85 PPARG (0.67) PPARGPPARACYP2C9KCNH2
SCHEMBL5229653 0.84 PPARG (0.52) PPARGPPARACYP2C9KCNH2
SCHEMBL5226601 0.83 PPARG (0.57) PPARGPPARACYP2C9KCNH2PPARD
SCHEMBL5228797 0.82 PPARG (0.53) PPARGPPARAPPARD
SCHEMBL5228875 0.82 PPARA (0.51) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP claimed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO claimed
EP-1778654-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME Crystalgenomics, Inc. (KR) 2007-05-02 EP disclosed
WO-2006006832-A1 SULFAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION FOR UPREGULATION OF LIPID METABOLISM COMPRISING SAME CRYSTALGENOMICS, INC. (KR) 2006-01-19 WO disclosed